Prof Martin Dreyling at ASH 2014: Novel biologic therapies for non-Hodgkin lymphoma

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Martin Dreyling (Ludwig-Maximilians University of Munich, Munich, Germany) discusses novel biologic therapies for the management o... Author: EMJ Added: 03/27/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts